Nalaganje...
PD-1/PD-L1 Blockade after Transient Lymphodepletion to Treat Myeloma
Early phase clinical trials targeting the programmed death receptor-1/ligand-1 (PD-1/PD-L1) pathway to overcome tumor-mediated immunosuppression have reported promising results for a variety of cancers. This pathway appears to play an important role in the failure of immune reactivity to malignant p...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891840/ https://ncbi.nlm.nih.gov/pubmed/23616570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1202005 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|